Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

For this review, the USPSTF addressed the health benefits, including reduction in CHD events, CHD mortality, and overall mortality, of applying nontraditional risk factors to those identified as intermediate–risk by the Framingham CHD risk algorithm. The current evidence is insufficient to assess the balance of benefits and harms of using the nontraditional risk factors studied to screen asymptomatic men and women with no history of CHD to prevent CHD events. (I statement). The nontraditional risk factors included in this recommendation are high–sensitivity C–reactive protein (hs–CRP), ankle–brachial index (ABI), leukocyte count, fasting blood glucose level, periodontal disease, carotid intima–media thickness (carotid IMT), coronary artery calcification (CAC) score on electron–beam computed tomography (EBCT), homocysteine level, and lipoprotein(a) level.


   

Today in Cardiology...keeping you current

Acute Coronary Syndromes: Diagnosis and Management, Part I
Mayo Clinic Proceedings, 10/05/09

New Anticoagulants in Atrial Fibrillation
Seminars in Thrombosis and Hemostasis, 10/02/09

Acute medical management of the non-ST-segment elevation acute coronary syndromes (NSTE-ACS) in older patients
Archives of Gerontology and Geriatrics, 10/14/09

Today in Preventive Medicine...keeping you current

Homocysteine lowering interventions for preventing cardiovascular events
Cochrane Reviews, 10/19/09

Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09

Omega-3 fatty acids and heart failure
Current Atherosclerosis Reports, 11/12/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address